Mind the gap: Information and communication technologies, knowledge activities and innovation in the pharmaceutical industry

Technology Analysis and Strategic Management

Volumn 14, Issue 3, 2002, Pages 355-370

  Howells, Jeremy ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMMUNICATION; INFORMATION TECHNOLOGY; INNOVATION; PHARMACEUTICAL INDUSTRY;

EID: 0036724487     PISSN: 09537325     EISSN: None     Source Type: Journal    
DOI: 10.1080/0953732022000002159     Document Type: Article

References (72)

1. Generic knowledge strategies in the US pharmaceutical industry
2. Innovative productivity and returns to scale in the pharmaceutical industry
3. Using bibliometrics to measure firm knowledge: An analysis of the US pharmaceutical industry
4. The core competence of the corporation
5. Managing change in pharmaceutical industry RandD
6. Update on European patent extensions
7. Pharmaceutical manufacturing- A competitive advantage?
8. Strong medicine: The Glaxo SmithKline merger may prompt other big deals
9. Improving clinical trials cost management in biotech companies
10. Cost savings from e-development
11. Economies of scale in experimentation: Knowledge and technology in pharmaceutical RandD
12. Leschley rejects GSK RandD spin-off
13. Interfirm cooperation and startup innovation in the biotechnology industry
14. Small-firm formation in biotechnology: A comparison of France, Britain and Canada
15. Inter-organisational collaboration and the locus of innovation: Network learning in biotechnology
16. Learning from collaboration: Knowledge and networks in the biotechnology and pharmaceutical industries
17. Networks in transition: How industry events (re)shape interfirm relationships
18. Architectural innovation
19. Chemistry, manufacturing, and controls information in NDAs ANDAs, supplements, annual reports, and other regulatory filings
20. Joint ventures and collaboration in the biotechnology industry
21. Knowledge, integration and the locus of learning: An empirical analysis of process development
22. The RandD boundaries of the firm: An empirical analysis
23. High-Tech RandD
24. Technological change and network dynamics: Lessons from the pharmaceutical industry
25. Computer-based information systems for management: A survey
26. Architectural innovation
27. Managing the crisis in data processing
28. The evolution of integrative capability: Innovations in cardiovascular drug discovery
29. Measuring competence? Exploring firm effects in pharmaceutical research
30. When is virtual virtuous?
31. Articulating collaboration in a learning community
32. Virtual teams: The new way to work
33. Distributed work arrangements: A research framework
34. Managing virtual RandD organizations: Lessons from the pharmaceutical industry
35. Going global: The use of ICT networks in research and development
36. E-commerce: Implications for firm strategy and industry configuration
37. The diffusion and management of EDI: Barriers and opportunities in the UK pharmaceutical and healthcare industries
38. Expanding the reach of electronic commerce: The internet EDI alternative
39. Electronic commerce implementation: Knowledge-based analysis
40. Managing knowledge for strategic advantage in the virtual organization
41. Electronic markets and electronic hierarchies
42. From know-how to show-how? Questioning the role of information and communication technologies in knowledge transfer
43. Successful knowledge management projects
44. Big pharma fights discovery bottlenecks
45. Will new information and communication technologies improve the "codification" of knowledge
46. Many rivers to cross: From ICT to knowledge management systems
47. On knowledge management in the internet age
48. Knowledge, knowledge work and organisations: An overview and interpretation
49. Competing with intellectual capital
50. Core competencies, competitive advantage and market analysis: Forging the links
51. Organisational learning and core capabilities development: The role of IT
52. What's your strategy for managing knowledge?
53. Sense, scale and scope in pharmaceutical RandD
54. IT-intensive value innovation in the electronic economy: Insights from Marshall industries
55. Changing channels: The impact of the internet on distribution strategy
56. Untangling the value web
57. R and D networking in a pharmaceutical company: Some implications for human resource management
58. Cooperation in RandD in the pharmaceutical industry: The network as an organizational innovation governing technological innovation
59. RandD.com research to revenue
60. Capturing physicians
61. Cancer network boosts clinical trials
62. Organizational learning and communities-of-practice: Towards a unified view of working, learning and innovation
63. E-pharmacy questions sent to ECJ
64. Obtaining industry control: The case of pharmaceutical distribution industry
65. Technological discontinuities and organizational environments